Hinderling PH - Search Results

1

Pharmacokinetics and pharmacodynamics of sotalol in a pediatric population with supraventricular and ventricular tachyarrhythmia.

Saul JP, Ross B, Schaffer MS, Beerman L, Melikian AP, Shi J, Williams J, Barbey JT, Jin J, Hinderling PH; Pediatric Sotalol Investigators. Saul JP, et al. Among authors: hinderling ph. Clin Pharmacol Ther. 2001 Mar;69(3):145-57. doi: 10.1067/mcp.2001.113795. Clin Pharmacol Ther. 2001. PMID: 11240979 Free article. Clinical Trial.

2

Pharmacokinetic, pharmacodynamic, and safety evaluation of an accelerated dose titration regimen of sotalol in healthy middle-aged subjects.

Barbey JT, Sale ME, Woosley RL, Shi J, Melikian AP, Hinderling PH. Barbey JT, et al. Among authors: hinderling ph. Clin Pharmacol Ther. 1999 Jul;66(1):91-9. doi: 10.1016/S0009-9236(99)70058-5. Clin Pharmacol Ther. 1999. PMID: 10430114 Clinical Trial.

3

Single-dose pharmacokinetics of sotalol in a pediatric population with supraventricular and/or ventricular tachyarrhythmia.

Saul JP, Schaffer MS, Karpawich PP, Erickson CC, Epstein MR, Melikian AP, Shi J, Karara AH, Cai B, Hinderling PH. Saul JP, et al. Among authors: hinderling ph. J Clin Pharmacol. 2001 Jan;41(1):35-43. doi: 10.1177/00912700122009818. J Clin Pharmacol. 2001. PMID: 11144992 Clinical Trial.

4

Population pharmacokinetics and pharmacodynamics of sotalol in pediatric patients with supraventricular or ventricular tachyarrhythmia.

Shi J, Ludden TM, Melikian AP, Gastonguay MR, Hinderling PH. Shi J, et al. Among authors: hinderling ph. J Pharmacokinet Pharmacodyn. 2001 Dec;28(6):555-75. doi: 10.1023/a:1014412521191. J Pharmacokinet Pharmacodyn. 2001. PMID: 11999292 Clinical Trial.

5

Pharmacokinetics of sematilide in renal failure.

Shi J, Ripley E, Gehr TW, Sica DA, Dandekar KA, Hinderling PH. Shi J, et al. Among authors: hinderling ph. J Clin Pharmacol. 1996 Feb;36(2):131-43. doi: 10.1002/j.1552-4604.1996.tb04178.x. J Clin Pharmacol. 1996. PMID: 8852389 Clinical Trial.

6

Absolute bioavailability estimated from oral data.

Hinderling PH, Shi J. Hinderling PH, et al. J Pharm Sci. 1995 Mar;84(3):385-6. doi: 10.1002/jps.2600840323. J Pharm Sci. 1995. PMID: 7616383 No abstract available.

7

The pharmacokinetics and pharmacodynamics of fludarabine phosphate in patients with renal impairment: a prospective dose adjustment study.

Lichtman SM, Etcubanas E, Budman DR, Eisenberg P, Zervos G, D'Amico P, O'Mara V, Musgrave K, Cascella P, Melikian A, Hinderling PH, Ferrer JM, Williams GJ. Lichtman SM, et al. Among authors: hinderling ph. Cancer Invest. 2002;20(7-8):904-13. doi: 10.1081/cnv-120005903. Cancer Invest. 2002. PMID: 12449721

8

Kinetics and dynamics of sematilide.

Shi J, Lasser T, Koziol T, Hinderling PH. Shi J, et al. Among authors: hinderling ph. Ther Drug Monit. 1995 Oct;17(5):437-44. doi: 10.1097/00007691-199510000-00001. Ther Drug Monit. 1995. PMID: 8585104 Clinical Trial.

9

Single-dose interaction study of diprafenone HCl and propranolol HCl in healthy volunteers.

Hinderling PH, Tendolkar A, Dee CM, Barr WH, Seiberling M, Duerr H. Hinderling PH, et al. J Clin Pharmacol. 1995 Jul;35(7):721-9. doi: 10.1002/j.1552-4604.1995.tb04113.x. J Clin Pharmacol. 1995. PMID: 7560253 Clinical Trial.

10

The Pharmacokinetics of Potassium in Humans Is Unusual.

Hinderling PH. Hinderling PH. J Clin Pharmacol. 2016 Oct;56(10):1212-20. doi: 10.1002/jcph.713. Epub 2016 Mar 8. J Clin Pharmacol. 2016. PMID: 26854277 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters